Global Multi Cancer Early Detection Market is expected to be US$ 3,934.79 Million by 2032, at a CAGR of 16.7% from 2024 to 2032 | PMR
July 31, 2024 08:30 ET
|
Polaris Market Research & Consulting LLP
New York, USA, July 31, 2024 (GLOBE NEWSWIRE) -- Market Overview: The Multi Cancer Early Detection Market was estimated at USD 978.63 million in 2023. The market valuation is expected to be USD...
Multi Cancer Early Detection Market is Growing at Rapid Pace and Expected to Reach 23743.57 Million by 2031 | Latest InsightAce Study
September 06, 2023 05:42 ET
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, Sept. 06, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Multi Cancer Early Detection Market by Type...
VisionGate’s Cell-CT™ 3D Cellular Imaging Platform Detects the Presence of Cancer-Associated Cells (CACs) that have undergone Malignancy Associated Change (MAC)
April 16, 2018 09:23 ET
|
VisionGate, Inc.
SEATTLE, WA, April 16, 2018 (GLOBE NEWSWIRE) -- VisionGate, a clinical stage oncology pharmaceutical and diagnostics company, today presented a breakthrough research study demonstrated its Cell-CT™...